Trade ICU Medical Inc - ICUI CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.26 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 136.99 |
| Open | 134.58 |
| 1-Year Change | 39.19% |
| Day's Range | 134.55 - 136.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 135.45 | 1.90 | 1.42% | 133.55 | 136.68 | 133.55 |
| Apr 24, 2025 | 136.99 | 4.74 | 3.58% | 132.25 | 137.78 | 132.25 |
| Apr 23, 2025 | 132.06 | -1.61 | -1.20% | 133.67 | 138.34 | 132.01 |
| Apr 22, 2025 | 130.56 | -6.13 | -4.48% | 136.69 | 138.44 | 125.75 |
| Apr 21, 2025 | 136.45 | 4.50 | 3.41% | 131.95 | 137.06 | 131.95 |
| Apr 17, 2025 | 138.59 | 1.23 | 0.90% | 137.36 | 140.86 | 136.94 |
| Apr 16, 2025 | 139.02 | 1.97 | 1.44% | 137.05 | 140.29 | 136.30 |
| Apr 15, 2025 | 139.25 | -1.10 | -0.78% | 140.35 | 141.23 | 136.32 |
| Apr 14, 2025 | 140.24 | -3.24 | -2.26% | 143.48 | 143.76 | 138.27 |
| Apr 11, 2025 | 142.51 | 7.19 | 5.31% | 135.32 | 144.35 | 133.37 |
| Apr 10, 2025 | 138.23 | -2.89 | -2.05% | 141.12 | 143.16 | 134.25 |
| Apr 9, 2025 | 150.90 | 20.84 | 16.02% | 130.06 | 151.86 | 130.06 |
| Apr 8, 2025 | 133.62 | -11.14 | -7.70% | 144.76 | 145.83 | 132.73 |
| Apr 7, 2025 | 142.20 | 11.01 | 8.39% | 131.19 | 144.90 | 130.11 |
| Apr 4, 2025 | 139.33 | 8.28 | 6.32% | 131.05 | 143.27 | 131.00 |
| Apr 3, 2025 | 141.51 | 11.56 | 8.90% | 129.95 | 147.95 | 129.94 |
| Apr 2, 2025 | 140.26 | 5.46 | 4.05% | 134.80 | 143.63 | 134.80 |
| Apr 1, 2025 | 137.60 | 5.24 | 3.96% | 132.36 | 139.71 | 132.36 |
| Mar 31, 2025 | 138.79 | 2.49 | 1.83% | 136.30 | 140.27 | 135.36 |
| Mar 28, 2025 | 140.01 | 1.01 | 0.73% | 139.00 | 142.83 | 138.41 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ICU Medical Company profile
About ICU Medical Inc
ICU Medical, Inc. (ICU) is engaged in the development, manufacturing and sale of medical products used in infusion therapy and critical care applications. The Company’s product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. Its critical care products help clinicians get real-time access to patients’ hemodynamic and cardiac status with a portfolio of monitoring systems and advanced sensors and catheters. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. It sells its products through its direct sales force and through independent distributors. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, ICU Medical Inc revenues increased 4% to $1.32B. Net income increased 19% to $103.1M. Revenues reflect Infusion Consumables segment increase of 17% to $555.2M, Critical Care segment increase of 1% to $49.3M, United States segment increase of 3% to $941.8M, EMEA segment increase of 11% to $147.5M. Net income benefited from Restructuring Charges/Provisions decrease of 37% to $18M (expense).
Equity composition
Common Stock $.10 Par, 03/11, 80M auth., 14,855,000 issd., less 1,123,000 shs. in Treas @ $38.95M. Insiders & Strategic holders own 11.33%. IPO 3/92, 1.3M shares @ $11.00 by Sutro& Co., Inc. PO 7/95, 2.07M shares @ $12 by Rodman & Renshaw, Inc. 3/02, 4/93, 3-for-2 stock splits. FY'03 Q4 are being restated.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
951 Calle Amanecer
SAN CLEMENTE
CALIFORNIA 92673-6212
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com